Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-02-08
2011-02-08
Rao, Manjunath N (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C530S363000
Reexamination Certificate
active
07884068
ABSTRACT:
A composition comprising an albumin-based colloid composition having at least one protected thiol region, method of making the same, and method for use, including treating hypovolemic conditions such as capillary leak syndrome and shock, are disclosed.
REFERENCES:
patent: 2727027 (1955-12-01), Monson et al.
patent: 4101380 (1978-07-01), Rubinstein et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 5324844 (1994-06-01), Zalipsky
patent: 5583114 (1996-12-01), Barrows et al.
patent: 5650234 (1997-07-01), Dolence et al.
patent: 5704358 (1998-01-01), Zikria
patent: 5714511 (1998-02-01), Saavedra et al.
patent: 5733563 (1998-03-01), Fortier
patent: 5756481 (1998-05-01), Arnal et al.
patent: 5952009 (1999-09-01), Neurath et al.
patent: 6063764 (2000-05-01), Creasey et al.
patent: 6129912 (2000-10-01), Hortin et al.
patent: 6344197 (2002-02-01), Fisher et al.
Cha, M-K., et al. 1996 Biochem. Biophys. Res. Comm. 222: 619-625.
Matejtschuk, P., et al. 2000 British Journal of Anaesthesia 85(6): 887-895.
Shewale, J.G., et al. 1984 J Biol Chem 259(8): 4947-4956.
Palmiter, R.D., et al. 1978 PNAS 75(1): 94-98.
Lee, H., et al. 2000 Archives Biochem Biophys 380(2): 309-318.
Masaki, K., et al. 2000 Protein Engineering 13(1): 1-4.
Matejtschuk, P., et al. 2000 British Journal of Anaesthesia 85(6): 887-95.
Conley et al. Britannica Encyclopedia Blood article (21 pages), 2007.
Wu Lin, Martin C. Garnett, Etienne Schacht, Stanley S. Davis, Lisbeth Illum,Preparation and in vitro characterization of HAS-mPEG nanoparticles, International Journal of Pharmaceutics , 189 (1999), pp. 161-170.
Angus, D.C., Wax, R.S.,Epidemiology of Sepsis—An Update, Critical Care Medicine.29 (7) (2001) S109-S116.
Baue, A.E., Durham, R., Faist, E.,Systemic Inflammatory Response Syndrome(SIRS)Multiple Organ Dysfunction Syndrome(MODS),Multiple Organ Failure(MOF)Are We Winning The Battle?, Shock. 10 (2)(1998) 79-89.
Roberts, J.S., Bratton, S.L.Colloid volume expanders: problems, pitfalls and possibilities, Drugs. 55(5)(1998) 621-630.
Berger, A.,Why albumin may not work(editor's commentary). BMJ, (1998) 317:240.
Doweiko, J.P. And Nompleggi, D.J.,Interactions of Albumin and Medications, J. Parenter. Enteral. Nutr. 15, (1991) 212-214.
Emerson, T.E.,Unique features of albumin: a brief review, Crit Care Med. 17(7) (1989) 690-694.
Margarson, M.P., Soni, N.,Serum Albumin: touchstone or totem? Anaesthesia, 53 (1998) 789-803.
McClelland,Human albumin administration in critically ill patients, BMJ, 317 (1998) 882-886.
Wilkes,M. And Navickis, R.J.,Patient survival after human albumin administration, Ann Intern Med. 135 (2001) 149-164.
Cochrane Injuries Group Albumin Reviewers,Human albumin administration in critically ill patients: systematic review of randomized controlled trials, BMJ 317(1998) 235-40.
Delgado, C., Francis, G.E., and Fisher D., The uses and properties of PEG-linked proteins. Critical Reviews in Therapeutic Drug Carrier Systems. 9(3,4) (1992) 249-304.
Abuchowski, A., Van Es, T., Palozuk, N.C., and Davis. F.,Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol, J. Biol Chem. 252(1)(1997) 3578-3581.
Kozlowski A; Charles SA; Harris JM,Development of pegylated interferons for the treatment of chronic hepatits C, BioDrugs 15 (2001) 419-29.
Conover, C, Malatesta, P., Lejuene, Chang, C.L., and Shorr, R.G.L.,The effects of hemodilution with polyethylene glycol bovine hemoglobin(Peg-Hb)in a conscious porcine model, J Inves Med. 44(5)(1996) 238-246.
Conover, C.D., Lejuene, L., Shum, K., Gilbert, C., and Shorr, R.G.,Physiological effect of polyethylene glycol conjugation of stroma-free bovine hemoglobin in the conscious dog after partial exchange transfusion, Artif Organs. 21(5)(1997)369-78.
Conover, C.D., Linberg, R., Lejuene, L., Nagy, M., and Shum, K.L.,PEG-hemoglobin as a resuscitation solution in the treatment of hypovolemic shock in the anesthetized rat, Artif. Organs 23(12)(1999) 1088-1098.
Yeh, T., Parmar, J.M., Rebeyka, I.M., Lofland, G.K., Allen, E.L., Dignan, R.J., et al.Limiting edema in neonatal cardiopulmonary bypass with narrow-range molecular weight hydroxyethyl starch, J. Thorac Cardiovasc Surg. 104 (1992) 659-65.
Axon, R.N., Baird, M.S., Lang, J.D., Brix, A.E., Nielson, V.G.,Pentalyte Decreases Lung Injury After Aortic Occlusion-Reperfusion, Am J. Reespir. CritCare Med. 157 (1998).
Heneka, M.T., Loschmann, P.A. Osswald, H.,Polymerized Hemoglobin Restores Cardiovascular and Kidney Function in Endotoxin-induced Shock in the Rat, J.Clin.Invest. 99(1997) 47-54.
Zoellner, H., Hofler, M., Beckmann, R., Hufnagel, Vanyek, E., Blelek E., et al.,Serum albumin is a specific inhibitor of apoptosis in human endothelial cells, J. Cell Science, 109 (1996) 2571-2580.
Cantin, A.M., Paquette, B., Richter, M., and Larivee, P.,Albumin-mediated regulation of cellular glutathione and nuclear factor Kappa B activation, Am J Respir Crit Care Med, 162(2000) 1539-1546.
Assaly, R., Olson, D., Hammersely, J., Fan, P.S., Liu J., Shapiro J., Kahaleh, B.,Initial Evidence of Endothelial Cell Apoptosis as a Mechanism of Systemic Capillary Leak Syndrome, Chest:120(2001) 1301-1308.
Quinlan, G.J., Margarson, M.P., Mumby, S., Evans, T.W., Gutteridge, J.M.C.,Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion, Clin. Sci. 95 (1998) 459-465.
Filep, J.G., Delalandre, A., Beauchamp, M.,Dual role for nitric oxide in the regulation of plasma volume and albumin escape during endotoxin shock in conscious rats, Circ Res., 81 (1997) 840-847.
Tanford, C., Physical Chemistry of Macromolecules, John Wiley & Sons, (1961) p. 217.
Vandegriff, K.D., McCarthy, M., Rohlfs, R.J., and Winslow, R.M.,Colloid osmotic properties of modified hemoglobin: chemically cross-linked versus polyethyethylene glycol surface-conjugated, Biophys. Chem. 69 (1997) 23-30.
Laemmli, U.K.,Cleavage of structural proteins during the assembly of the head of bacteriophage, T4, Nature, 227 (1970) 6980-6985.
Johnson, D.E.,Applied multivariate Methods for Data Anaylsis, Duxbury Press, (1998) page 319-121.
Bullock, J.,Characterization of Polyethelene glyol-Modified Superoxide Dismutase: Comparison of Capillary Electrophoresis and Marix-Assisted Laser Desorption/Ionization Mass Spectometry, Anal.Chem. 68 (1996) 3258-3264.
Veronese, F.M.,Peptide and protein PEGylation: a review of problems and solutions, Biomaterials 22 (2001) 405-417.
Nathan, C., Inducible Nitric Oxide Synthase:What Difference Does It Make? J.Clin.Invest., 100(10)(1997) 2417-2423.
Hubbard, J.D., Janssen, H.F., Increased microvascular permeability in canine endotoxic shock: protective effects of ibuprofen, Circ Shock 26 (1988) 169-183.
Taylor, AE, Granger DN,Exchange of macromolecules across the microcirculation. Handbook of Physiology, The Cardiovascular System IV, Am Physiol Soc, 4(1)11 (1984) 467-520.
Abuchowski, A., Van ES, T., Palozuk, N.C., and Davis, F.,Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol, J Biol Chem. 252(11)(1977) 3578-3581.
Hershey, S.G. And Altura, Burton M.; Effect of Pretreatment With Aggregate Albumin on Reticuloendothelial System Activity and Survival After Experimental Shock; Proceedings of the Society for Experimental Biology and Medicine; Aug.-Sept. 1996—vol. 122, No. 4.
Assaly Ragheb A.
Dignam J. David
Shapiro Joseph I.
Emch, Schaffer, Schaub & Porcello Co. LPA
Rao Manjunath N
Tsay Marsha M
LandOfFree
Albumin-based colloid composition having at least one... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Albumin-based colloid composition having at least one..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Albumin-based colloid composition having at least one... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2619989